Comparing the Effects of Sub-Occipital Myofascial Release With and Without SNAG on People With Cervicogenic Dizziness.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-54
SponsorRiphah International University

About this trial

Cervicogenic dizziness is defined as a sensation of rotation, resulting from an alteration of the neck proprioceptive afferents of the upper cervical spine.Sub-occipital Release, a type of Myofascial Release (MFR) is a form of manual therapy technique which can be used for the treatment of cervicogenic dizziness. Sub-occipital muscles, dura matter and C2 vertebrae are connected to each other through the fascia. Sustained natural apophyseal glides (SNAGs) are also an effective treatment for cervicogenic dizziness. This study aim to determine Comparative Effect of Sub-Occipital Myofascial release with and without Sustained Natural Apophyseal Glide among patients with Cervicogenic Dizziness.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cervicogenic dizziness patients both male and female.

Age group between 22 to 54 Years old.

Passive Accessory Assessment of the UCS (C0-1, C1-2, C2-3).

Dizziness related to either movements or positions of the cervical spine, or occurring with a stiff or painful neck.

Disqualifiers

Conditions for which manual therapy is contraindicated

Traumatic brain injury

Previous surgery to the upper cervical spine and marked cervical spine disc protrusion

By neurologist .Vestibular disorders (e.g. Benign Paroxysmal Positional Vertigo, Meniere's disease, peripheral vestibulopathy)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Sub Occipital Myofascial release and (SNAGS).

    Other intervention

    The patient will instruct to be seated then will turned his head toward direction that will cause his dizziness. when subject will turn his head, The manual therapist will perform a constant PA glide (using his thumbs one over the other) to upper cervical C1 or C2 vertebra (Oriented toward patient's eyeballs). If flexion or extension movement will provoke the dizziness, an anterior glide will apply to the C2 spinous process. If rotation will provoke dizziness, then an anterior glide will be applied to the C1 transverse process.

  • Sub Occipital Myofascial release.

    Other intervention

    When using the technique, the patient will be in Upward-facing position with their head fully aided on the therapist's hands. The therapist will put three middle fingers simply inferior to the nuchal line, raise the tips of the fingers in the direction of the ceiling, and then simply pull them upward.

Treatment groups

42 Participants
are divided into 2 treatment groups
Group A: Sub Occipital Myofascial release and Sustained Natural Apophyseal Glide (SNAGS).Active comparator 1 intervention
Group B: Sub Occipital Myofascial releaseActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Visual Analogue Scale (VAS)

The dizziness intensity was registered with a VAS, a valid and reliable tool for measuring dizziness intensity (reliability test-retest of this VAS is r = 0.85-0.96) .A continuous vertical line of 100 mm was anchored by two verbal descriptors ("no dizziness" and "worst imaginable dizziness"), and each end of the line had a mark; the subjects had to mark on the line the worst perceived dizziness since the last appointment (wVAS). Although it is a subjective and individual scale of the patient, it allows us to register the intensity of dizziness quickly, and its use in the clinic is widespread.

Time frame
4 weeks

Secondary outcomes

1

Dizziness Handicap Inventory (DHI)

The impact of dizziness on quality of life is often assessed by the Dizziness Handicap Inventory (DHI). The DHI contains 25 items, and a total score (0-100 points) is obtained by summing ordinal scale responses, higher scores indicating more severe handicap. The scale was developed to capture various sub-domains of self-perceived handicap and comprises 7 physical, 9 functional, and 9 emotional questions

Time frame
4 weeks

Other outcomes

1

Numerical Pain Rating Scale (NPRS)

This scale will be used to measure the patient's level of pain. The numbers on this scale go from 0 to 10. "No pain" is denoted by a score of 0, and "worst pain" by a score of 10. High test-retest reliability has been demonstrated using NPRS (r = 0.96 and 0.95, respectively)

Time frame
4 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: